Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

BACKGROUND: Hepatitis B e antigen (HBeAg) seroconversion represents an endpoint of treatment of chronic hepatitis B virus (HBV) infections. METHODS: We have studied whether levels of serum hepatitis B virus ribonucleic acid (HBV RNA) during pegylated interferon alfa-2a treatment might be helpful for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Virol J
Autors principals: Jia, Wen, Zhu, Men Qi, Qi, Xun, Wang, Ting, Wen, Xiao, Chen, Pei Dong, Fan, Qing Qi, Zhang, Wen-Hong, Zhang, Ji Ming
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505123/
https://ncbi.nlm.nih.gov/pubmed/31064399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-019-1152-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars